Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVERSEP: Ibuprofen for Fever in Sepsis
NCT04227652Completed
- Sponsor
- University Hospital Ostrava
- Start
- Sep 2013
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ibuprofen in sepsis (2 arms), sponsored by University Hospital Ostrava. Primary endpoint: Sequential Organ Failure Assessment up to 7 days. Started Sep 2013; status: completed.
02
Drugs
ibuprofen
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04227652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227652.